Waverly Advisors LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 21.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,799 shares of the medical equipment provider's stock after buying an additional 2,064 shares during the period. Waverly Advisors LLC's holdings in Intuitive Surgical were worth $6,159,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Atala Financial Inc bought a new stake in Intuitive Surgical during the fourth quarter valued at about $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $26,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Hurley Capital LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Institutional investors own 83.64% of the company's stock.
Intuitive Surgical Stock Down 0.6%
Shares of ISRG stock traded down $3.13 on Friday, hitting $539.54. The company had a trading volume of 1,138,538 shares, compared to its average volume of 1,644,578. Intuitive Surgical, Inc. has a twelve month low of $396.15 and a twelve month high of $616.00. The firm has a market cap of $193.38 billion, a P/E ratio of 84.17, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The company has a 50-day moving average price of $510.44 and a 200-day moving average price of $537.67.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the business earned $1.50 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on ISRG shares. Bernstein Bank lifted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday, January 27th. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research note on Monday, January 27th. Wells Fargo & Company upped their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $596.05.
Check Out Our Latest Report on ISRG
Insider Activity at Intuitive Surgical
In other news, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. The trade was a 60.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 2,401 shares of the company's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the transaction, the executive vice president now directly owns 353 shares of the company's stock, valued at approximately $205,093. The trade was a 87.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock worth $16,865,621 in the last three months. Company insiders own 0.70% of the company's stock.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.